Human Galanin Modulates Human Colonic Motility in Vitro Characterization of Structural Requirements

References

• Tatemoto K, Rokaeus A, Jörnvall H, McDonald T J, Mutt V. Galanin—a novel biologically active peptide from porcine intestine. FEBS Lett 1983; 164: 124–8
   PubMed Web of Science ®Google Scholar
• Schmidt W E, Kratzin H, Eckart K, Drews D, Mundkowski G, Clemens A, et al. Isolation and primary structure of pituitary human galanin, a 30 residue non-amidated peptide. Proc Natl Acad Sci USA 1991; 88: 11435–9
   PubMedGoogle Scholar
• Evans H F, Shine J. Human galanin: molecular cloning reveals a unique structure. Endocrinology 1991; 129: 1682–4
   PubMed Web of Science ®Google Scholar
• Bersani M, Johnsen A H, Hojrup P, Dunning B E, Andreas J J, Holst J J. Human galanin: Primary structure and identification of two molecular forms. FEBS Lett 1991; 283: 189–94
   PubMedGoogle Scholar
• Rokaeus A. Galanin: a newly isolated biologically active neuropeptide. Trends Neurosci 1987; 10: 158–64
   Web of Science ®Google Scholar
• Bartfai T, Fisone G, Langel U. Galanin and galanin antagonists: molecular and biochemical perspectives. TIPS 1992; 13: 312–7
   PubMed Web of Science ®Google Scholar
• Rattan S. Role of galanin in the gut. Gastroenterology 1991; 100: 1762–8
   PubMedGoogle Scholar
• Ekblad E, Håkanson R, Sundler F, Wahlstedt C. Galanin: neuromodulatory and direct contractile effects on smooth muscle preparations. Br J Pharmacol 1985; 86: 241–6
   PubMedGoogle Scholar
• Schmidt W E, Siegel E G, Kratzin H, Creutzfeldt W. Isolation and primary structure of tumor-derived peptides related to human pancreastatin and chromogranin A. Proc Natl Acad Sci USA 1988; 85: 8231–5
   PubMed Web of Science ®Google Scholar
• Wallenstein S, Zucker C L, Fleiss J L. Some statistical methods useful in circulation research. Circ Res 1980; 47: 1–9
   PubMed Web of Science ®Google Scholar
• Maggi C A, Patacchini R, Santicioli P, Giuliani S, Turini D, Barbanti G, et al. Human isolated small intestine: motor responses of the longitudinal muscle to field stimulation and exogenous neuropeptides. Naunyn Schmiedebergs Arch Pharmacol 1989; 339: 415–23
   PubMed Web of Science ®Google Scholar
• Burleigh D E, Furness J B. Distribution and actions of galanin and vasoactive intestinal peptide in the human colon. Neuropeptides 1990; 16: 77–82
   PubMedGoogle Scholar
• Bennett A, Stamford I F, Sanger G J, Bloom S R. The effects of various peptides on human isolated gut muscle. J Pharm Pharmacol 1992; 44: 960–7
   PubMedGoogle Scholar
• Ekblad E, Ambjörnsson E, Ekman R, Håkanson R, Sundler F. Neuropeptides in the human appendix. Distribution and motor effects. Dig Dis Sci 1989; 34: 1217–30
   PubMed Web of Science ®Google Scholar
• Katsoulis S, Schmidt W E, Schwörer H, et al. Effects of galanin, its analogues and fragments on rat isolated fundus strips. Br J Pharmacol 1990; 101: 297–300
   PubMedGoogle Scholar
• Rossowski W J, Zacharia S, Jiang N-Y, Mungan Z, Mills M, Ertan A, et al. Galanin: structure-dependent effect on pancreatic amylase secretion and jejunal strip contraction. Eur J Pharmacol 1993; 240: 259–67
   PubMedGoogle Scholar
• Kuwahara A, Ozaki T, Yanaihara N. Galanin suppresses neurally evoked contractions of circular muscle in the guinea-pig ileum. Eur J Pharmacol 1989; 164: 175–8
   PubMedGoogle Scholar
• Fox J ET, Brooks B, McDonald T J, Barnett W, Kostolanska F, Yanaihara C, et al. Actions of galanin fragments on rat, guinea pig, and canine intestinal motility. Peptides 1988; 9: 1183–9
   PubMedGoogle Scholar
• Chakder S, Rattan S. Effects of galanin on the oppossum internal anal sphincter: structure-activity relationship. Gastroenterology 1991; 100: 711–8
   PubMedGoogle Scholar
• Mochizuki T, Ishikawa J, Ohshima K, Greeley G H, Jr, Yanaihara N, et al. Effects of galanin fragments on insulin release from the isolated perfused pancreas. Biomed Res 1992; 13: 203–13
   Google Scholar
• Yanaihara N, Mochizuki T, Iguchi K, Hoshinon M, Nagashima T, Ishikawa J, . A structure-function relationships of galanin. Galanin, T Hökfelt, T Bartfai, D Jacobowitz, D Ottoson, et al. Macmillan Education Ltd, New York 1991; 185–96
   Google Scholar
• Amiranoff B, Lorinet A-M, Yanaihara N, Laburthe M. Structural requirement for galanin action in the pancreatic β cell line Rin m5F. Eur J Pharmacol 1989; 163: 205–7
   PubMedGoogle Scholar
• Gallwitz B, Schmidt W E, Schwarzhoff R, Creutzfeldt W. Galanin: structural requirements for binding and signal transduction in Rin m5F insulinoma cells. Biochem Biophys Res Commun 1990; 172: 268–75
   PubMedGoogle Scholar
• Mungan Z, Ozmen V, Ertan A, Coy D H, Baylor L M, Rice J C, et al. Structural requirements for galanin inhibition of pentagastrin-stimulated gastric acid secretion in conscious rats. Eur J Pharmacol 1992; 214: 53–7
   PubMedGoogle Scholar
• Bartfai T, Bedecs K, Land T, Langel Ü, Bertorelli B, Girotti P, et al. High affinity chimeric peptide that blocks the neuronal actions of galanin in the hippocampus, locus caeruleus, and spinal cord. Proc Natl Acad Sci 1991; 88: 10961–5
   PubMed Web of Science ®Google Scholar
• Pramanik A, Ögren S O. Galanin-evoked acetylcholine release in the rat striatum is blocked by the putative galanin antagonist M15. Brain Res 1992; 574: 317–9
   PubMedGoogle Scholar
• Lindskog S, Ahrén B, Land T, Langel Ü, Bartfai T. The novel high-affinity antagonist, galantide, blocks the galanin-mediated inhibition of glucose-induced insulin secretion. Eur J Pharmacol 1992; 183: 183–8
   Google Scholar
• Gu Z-F, Rossowski W J, Coy D H, Tapas K, Pradhan K, Jensen R T. Chimeric galanin analogs that function as antagonists in the CNS are full agonists in gastrointestinal smooth muscle. J Pharmacol Exp Ther 1993; 266: 912–8
   PubMed Web of Science ®Google Scholar
• Yanaihara N, Mochizuki T, Takatsuka N, Iguchi K, Sato K, Kakuyama H, et al. Galanin analogues: agonist and antagonist. Regul Pept 1993; 46: 93–101
   PubMed Web of Science ®Google Scholar
• Katsoulis S, Clemens A, Schwörer H, Schlemminger R, Creutzfeldt W, Schmidtet W E. Effect of non-amidated human galanin on human colonic motility in vitro: structure-activity relationship. Gastroenterology 1992; 102: 466
   Google Scholar